Latest Biotechnology, Pharmaceutical and Healthcare News

17:53 EDT 28th May 2015 | BioPortfolio

Showing News Articles 1–25 of 410,000+

Thursday 28th May 2015

Revolutionary Mobile App Introduces a New Way to Practice Medicine

DrNow App Connects Physicians and Patients Through House-Call Model Innovative new mobile application, DrNow, introduces medical providers with a revolutionary way to practice medicine. With a nod to the original house-call model of doctor-patient interaction, DrNow allows patients to request a physician through the app to treat them in the comfort of ...

Padlock picks up unwanted GSK assets

As GlaxoSmithKline continues to focus its resources on its main areas of interest like oncology, vaccines and respiratory drugs, the big pharma is selling off some of its unwanted assets.

UC Davis Research Finds That Restricting Firearms Access for People who Misuse Alcohol May Prevent Violence

Restricting access to firearms for people who misuse alcohol could prevent firearm violence, but policies that more clearly define alcohol misuse should be developed to facilitate enforcement, according to a review of existing research and public policies by the UC Davis Violence Prevention Research Program. SACRAMENTO, Calif. (PRWEB) May 28, 2015 Restricting access to firearms for people who mis...

CORRECTING and REPLACING DIA Annual Meeting to Address Future Innovation and Integrated Approach to Advance the Development of Health Care Products

First paragraph, third sentence of release dated May 20, 2015, should read: ...and Christopher P. Austin, MD, Director, National Center for Advancing Translational Sciences... (instead of ...and Christopher P. Austin, MD, Director, National Center for Advancing Translational Science...) The corrected release reads: DIA ANNUAL MEETI...

Advanced Bionics Announces TÜV Approval of Naída CI Q90 EAS

-- The World’s Newest, Most Advanced Electro Acoustic Stimulation (EAS) System Receives Regulatory Approval for Commercial Release in Europe -- Advanced Bionics (AB), a global leader in cochlear implant technology and a company of the Sonova Group, announced today that the new Naída CI Q90 EAS received TÜV approval for distribution in Europe. With the ...

Tic Tac launches flavor-changing Mixers

David SalazarTic Tac recently rolled out a new addition to its line of mints — flavor-changing Tic Tac Mixers.  read more

Merck Submits U.S. New Drug Application for Grazoprevir/Elbasvir, an Investigational Once-Daily, Single Tablet Combination Therapy, for Treatment of Chronic Hepatitis C Genotypes 1, 4, and 6 Infection

Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the company has submitted a New Drug Application to the U.S. Food and Drug Administration (FDA) for grazoprevir/elbasvir (100mg/50mg), an investigational once-daily, single tablet combination therapy for the treatment of adult patients with chronic hepatitis C genotyp...

Synta Announces Presentations at the 2015 ASCO Annual Meeting

Feasibility of Ganetespib Combination Therapy Demonstrated in Three Investigator-Sponsored Trials STA-12-8666 Results in Pediatric Sarcoma Models Highlighted in Poster Discussion Session Synta Pharmaceuticals Corp. (NASDAQ: SNTA) today announced that Phase 1 clinical results from three investigator-sponsored trials evaluating ganetespib...

NMEDA Members Team Up To Provide Mobility Solutions: National Mobility Awareness Month Contest To Award Four Wheelchair Accessible Vehicles

NMEDA will award four “Local Heroes” a wheelchair accessible vehicle tailored to their needs. The vehicles are provided by Chrysler, who will partner with ElDorado Mobility to deliver a customized Dodge Caravan, Toyota Mobility, who will partner with BraunAbility to deliver an all-new Toyota Sienna, Valley Honda Dealers, who will partner with Vantage Mobility International (VMI) to deliver an ...

Fitch Releases Report on Einstein Healthcare Network, PA

Fitch Ratings has published a report on Einstein Healthcare Network, PA. The report is available at 'www.fitchratings.com'. Additional information is available at 'www.fitchratings.com'. Einstein Healthcare Network, Pennsylvania

FDAnews Announces — Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process Webinar, June 23, 2015

On June 23, 2015, FDAnews is offering the combined knowledge and expertise of two leading intellectual property attorneys from the international law firm Duane Morris in the webinar Success Strategies for Biosimilars Approval: A Roadmap to the 351(k) Application Process. Firm partner Kevin Nelson and Associate Dr. Patrick Gallagher will show how to use the FDA’s guidance and prior decisions to g...

Rigaku Publishes New Method for Fused Bead Analysis of Various Oxide Materials for Wide Concentration Ranges on Benchtop WDXRF

Rigaku Corporation has published a new Application Note describing the analysis of a variety of oxides by X-ray fluorescence (XRF) using the fusion method. The Woodlands, Texas (PRWEB) May 28, 2015 Rigaku Corporation today announced the publication of a new X-ray fluorescence (XRF) technique for the analysis of a variety of oxides using the fusion method. Rigaku Application Note XRF 1048 demonstr...

Baxter and Baxalta Executives to Present at the Goldman Sachs 36th Annual Global Healthcare Conference

Executives from Baxter International Inc. (NYSE: BAX) and Baxalta Incorporated will present at the Goldman Sachs 36th Annual Global Healthcare Conference on Wednesday, June 10, 2015. Baxalta will present at 12:40 p.m. (CDT) and Baxter will present at 3:20 p.m. (CDT). The live webcast of both presentations can be accessed from the Baxter corporate ...

ATI Discovers Defective Rotary Crop Shear Component at its Hot-Rolling and Processing Facility

Allegheny Technologies Incorporated (NYSE: ATI) said today that, during routine maintenance, it discovered a defective component in the rotary crop shear (RCS) at its Hot-Rolling and Processing Facility (HRPF). As a result, the RCS is expected to be offline until at least the end of September 2015. The RCS is used in the production process to cut the head ...

Rite Aid targeting net new store growth for the future

Michael JohnsenRite Aid is looking forward to a robust store growth spate in the coming years, the chairman and CEO John Standley tells analysts.  read more

Heron Therapeutics Announces Positive Results from Phase 3 MAGIC Study of SUSTOL®

-Primary endpoint achieved -SUSTOL, as part of a three-drug regimen, is the first 5-HT3 antagonist to demonstrate superiority to standard-of-care for delayed nausea and vomiting after HEC -SUSTOL-based regimen was associated with significantly reduced nausea and improved patient satisfaction -Conference call and webcast Fr...

Veeva Announces Fiscal 2016 First Quarter Results

Total Revenues of $89.9M, up 35% Year-over-year; Subscription Services Revenue of $68.9M, up 42% Year-over-year Veeva Systems Inc. (NYSE:VEEV), a leading provider of industry cloud solutions for life sciences, today announced results for its fiscal first quarter ended April 30, 2015. “We are well-positioned as one of the top softwa...

Blood turned into nerve cells by Canadian researchers

Stem cells extracted from blood are converted into neural stem cells using patented technique The Canadian Press Posted: May 21, 2015 1:06 PM ET Last Updated: May 26, 2015 8:16 AM ET Mick Bhatia, director of McMaster University’s Stem Cell and Cancer Research Institute, says his lab hopes to eventually […]

Biogen 2015 Annual Shareholder Meeting Webcast

Biogen Inc. (NASDAQ: BIIB) announced today that its 2015 Annual Shareholder Meeting will be webcast live on Wednesday, June 10, 2015 at 9:00 a.m. ET. To access the live webcast, please visit Biogen’s Investors section at www.biogen.com. An archived version of the webcast will be available following the meeting. About Biogen ...

Provectus Biopharmaceuticals’ Abstract on Liver Cancer Accepted for Poster Presentation at 6th Asia-Pacific Primary Liver Cancer Expert Meeting

Phase 1 Study Poster to be Presented in Osaka, Japan, July 3, 2015 at 4:50 pm Local Time APPLE Conference Runs July 3-5, 2015 Provectus Biopharmaceuticals, Inc. (NYSE MKT: PVCT, http://www.pvct.com), a clinical-stage oncology and dermatology biop

Alnylam to Webcast Presentations at Upcoming June Investor Conferences

Alnylam Pharmaceuticals, Inc. (Nasdaq:ALNY), a leading RNAi therapeutics company, today announced that management will present a company overview at the following conferences in June: Jefferies 2015 Healthcare Conference on Thursday, June 4, 2015 at 8:30 a.m. ET in New York City

Stratasys and Creaform Announce Joint Marketing Agreement

Partnership brings together two market leaders in 3D printing and 3D scanning, enabling customers to leverage both technologies for high-quality 3D file input and output Stratasys Ltd. (Nasdaq:SSYS), a leading global provider of 3D printing and additive manufacturing solutions, announced a joint marketing

TripleTree Announces 2015 iAward Winners

Three connected health innovators are recognized from a group of highly relevant applicants Today, TripleTree announced the winners of its 7th Annual iAwards for Connected Health. The three winners were

Novocure Hosts First Glioblastoma-focused Hackathon to Develop New Support Tools for the GBM Brain Cancer Community

Technology experts and cancer patient advocates will #HackGBM in Chicago this week Novocure, a commercial stage oncology company, today kicks off Hack GBM: Finding Support Solutions for Glioblastoma Community Challenges, the first-ever hackathon to specifically address the needs of the glioblastoma (GBM) community. The hackathon will unite advocates an...

South Florida Lawmakers Discuss Medicaid Expansion At Forum

With a special legislative session set for next week, state lawmakers and hospital representatives discussed the future of health care in Florida, including Medicaid expansion.


Search BioPortfolio:
Loading
Advertisement
Advertisement

BioPortfolio's biotechnology, pharmaceutical, healthcare and medical device information service collates press releases, news articles and blogs from over 275 sources.